483
Anish Shah, M.D.FDA 483 - Anish Shah, M.D. - December 16, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Anish Shah, M.D. in Santa Rosa, CA, a clinical investigator, revealed significant data integrity issues and failures to adhere to the investigational plan. Observations included irregularities in vital sign reporting, non-contemporaneous record revisions, and the creation of altered study records. Additionally, the firm failed to conduct assessments as blinded and did not report all required prior medications to the sponsor.
Open in Dashboard
ID · f83dca2e-7f33-43ef-91c0-b60861656fec